Media Coverage

Devex: Population Council’s contraceptive innovations advance family planning

In its round-up of the of the International Conference on Family Planning Kigali, Rwanda, Devex cited two of the Council’s contraceptive innovations as major highlights of the 2018 conference.

During the week’s activities in Kigali, the Population Council’s Julia Bunting won the ICFP CEO FPitchfest, a competition to pitch the idea that will be transformative for the family planning community, with her announcement that the Council’s Nestorone®/Testosterone transdermal gel for male contraception is moving into phase two clinical trials.

The Council also hosted a side event highlighting opportunities for the introduction of new contraceptive options, including the Council’s Annovera contraceptive ring approved by the FDA this year, and their potential to contribute to meeting women’s diverse contraceptive needs.

Read more at Devex.

On Thursday, CEOs from 10 leading family planning organizations pitched “game-changing” ideas to the audience. Population Council’s Julia Bunting was the runaway winner after announcing a new contraceptive gel for men which has moved to phase two clinical trials.

Population Council also announced that Annovera — its new hormonal contraceptive ring for women — has been approved by the U.S. Food and Drug Administration. The device is well suited for use in low-income countries because it lasts for a year and does not require cold storage or regular visits to a clinic.